Since 2016, the guidelines for the management of adults with hospital-acquired pneumonia (HAP) / ventilator-associated pneumonia (VAP) have been updated in the United States, Europe, and China, respectively. The differences among these guidelines are demonstrated in this paper. The definition of VAP, how to evaluate the effect of anti-infection therapy, and the prevention strategy are controversial. The consensuses contain diagnostic value of respiratory secretions achieved by noninvasive way for VAP and shorter anti-infection course for VAP. Importantly, pathogenic spectrum for HAP in China is different from others, which is essential for clinical practice.
Citation： LIU Chao, CAO Bin. New sights of guidelines for the management of hospital-acquired pneumonia/ ventilator-associated pneumonia in adults. West China Medical Journal, 2019, 34(1): 7-11. doi: 10.7507/1002-0179.201711017 Copy